Effect of desmethylimipramine, iprindole and DL-erythro-alpha-(3,4-dichlorophenyl)-beta-(t-butyl amino) propanol HC1 on the metabolism of amphetamine.
D000433:1-Propanol / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000661:Amphetamine / Q000378:metabolism*; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002082:Butylamines / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D004357:Drug Synergism; D006321:Heart / Q000187:drug effects; D006591:Hexobarbital / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D009132:Muscles / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010243:Paralysis / Q000139:chemically induced; D051381:Rats; D012890:Sleep / Q000187:drug effects; D014316:Tritium; D015049:Zoxazolamine / Q000494:pharmacology
D000588:Amines; D000605:Amino Alcohols; D000928:Antidepressive Agents; D002082:Butylamines; D007211:Indoles; D014316:Tritium; D000433:1-Propanol; D015049:Zoxazolamine; D006591:Hexobarbital; D000661:Amphetamine; D003891:Desipramine; D009638:Norepinephrine